Two Top Officials in FDA Vaccine Review Office to Retire
WEDNESDAY, Sept. 1, 2021 (HealthDay News) -- Two senior leaders in the U.S. Food and Drug Administration vaccine review office are stepping down, but their departures will not slow efforts to combat the pandemic, the agency said Tuesday.
The retirements of Marion Gruber, M.D., director of the Office of Vaccines Research and Review at the FDA Center for Biologics Evaluation and Research, and Philip Krause, M.D., deputy director of the office, come as the agency mulls decisions about COVID-19 vaccine approvals, authorizations for younger children, and booster shots. Gruber will retire on Oct. 31 and Krause will step down in November, according to an internal FDA email sent by Peter Marks, M.D., director of the Center for Biologics Evaluation and Research, CNN reported.
The search for the next director of the Office of Vaccines Research and Review will begin soon and Marks will serve as the acting director, the email explained.
Acting FDA Commissioner Janet Woodcock, M.D., acknowledged to staff that the agency is operating in difficult times. "Following today's announcement that Marion and Phil have decided to retire, I wanted to reach out to reiterate my full support and complete confidence in your ability to continue delivering on the agency's mandate to deliver safe, effective, and high-quality vaccines to the American people," Woodcock said in an email to staff that was sent to CNN. "The issues are complex and the days are long, but please know the work you all have done to date and will continue to do in the days, weeks, and months ahead, will hopefully one day allow us to fully put COVID-19 behind us and better prepare us for future challenges."
Related Posts
AHA News: Health Coach Was Once an Overworked, Unhealthy New Mom Who Had a Stroke at 32
FRIDAY, Jan. 7, 2022 (American Heart Association News) -- Kelly Fucheck woke up...
1 in 5 U.S. Seniors Now Skip Meds Because of Cost
MONDAY, May 22, 2023 (HealthDay News) -- Many seniors skip or stretch...
Relative Risk for CVT Up After AZD1222 COVID-19 Vaccine
TUESDAY, June 14, 2022 (HealthDay News) -- The relative rates of hospital...
Beauticians, Hairdressers May Face Higher Odds for Ovarian Cancer
TUESDAY, July 11, 2023 (HealthDay News) -- When thinking of people in high-risk...